Hyphema is a potentially sight-threatening sequela of blunt trauma. Delayed healing time, poor visual outcome, and complications such as corneal blood staining, anterior and posterior synechiae, increased intraocular pressure, and glaucomatous optic atrophy are most often associated with hemorrhage filling more than one half of the anterior chamber. Rebleeds are most likely 3 to 5 days following injury, in children, in blacks (particularly if they have sickle cell disease), and in persons who have ingested aspirin or other antiplatelet compounds. Treatment of hyphema is controversial, and medical therapy (antibiotics, cycloplegics, steroids, aminocaproic acid) should be tailored to suit the needs of each case. Intraocular pressure-reducing medications may be required if there is significant elevation of IOP. The affected eye should be protected with a shield, and follow-up examinations should be conducted as necessary. Both the anterior and posterior eye should receive careful assessment.